Eli Lilly has reduced the cost of its popular obesity drug Zepbound for American patients. This move aims to make the treatment more accessible as demand for weight-loss medications skyrockets.

Eli Lilly is cutting what self-paying patients shell out for its blockbuster obesity drug Zepbound when they buy single-dose ...

Starting in 2026, people who are insured through Medicare will pay no more than $2,100 out of pocket on prescription drugs ...

Starting in 2026, people who are insured through Medicare will pay no more than $2,100 out of pocket on prescription drugs over the year. That cap may be much lower than $2,100 due to a quirk in ...

Online telehealth company Hims and Hers Health is launching its weight-loss membership and treatment plans in the United ...

Eli Lilly reduced Zepbound vial prices for self-paying patients via LillyDirect, aiming to lower obesity treatment costs and improve access. Price reductions include $50 off the 2.5 mg vial and $100 ...

The decision is the latest in a series of moves to make its GLP-1 blockbuster more widely available and affordable.

Online telehealth company Hims and Hers Health HIMS.N is launching its weight-loss membership and treatment plans in the UK ...

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight management has undergone a seismic shift. Zealthy is one of the fastest-growing telehealth weight-loss platforms in the ...

Some states are rethinking their coverage of GLP-1 drugs for weight loss as budgets tighten and Medicaid programs brace for ...

Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. Industry insiders are gearing up ...

Over the last few years, semaglutide has truly taken over. It's likely that you have more than one family member, friend, or ...